Climb Bio, Inc.

CLYM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001768446

SEC filings (opens in a new tab)

In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Climb Bio, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of CLYM: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Q2 2024	Change
Holders	21	47	+26
Shares	16.9M	49.9M	+33.1M (+196.1%)
Value	$46.2M	$354.8M	+$308.6M (+668.1%)

New holders (31)

Institutions that held Climb Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CLYM in Q2 2024
Institution	Shares	Value	% of portfolio
Deep Track Capital, LP	3,904,785	$27.8M	0.83%
Samsara BioCapital, LLC	3,261,393	$23.2M	4.85%
Janus Henderson Group PLC	3,253,988	$23.1M	0.01%
Boxer Capital, LLC	2,603,190	$18.5M	0.97%
Affinity Asset Advisors, LLC	1,670,661	$11.9M	1.87%
Adage Capital Partners GP, L.L.C.	670,362	$4.77M	0.01%
Ally Bridge Group (NY) LLC	500,000	$3.56M	2.12%
Sphera Funds Management Ltd.	215,179	$1.53M	0.25%
Walleye Capital LLC	196,390	$1.40M	0.01%
Ikarian Capital, LLC	100,000	$711.0K	0.22%
ADAR1 Capital Management, LLC	97,695	$694.6K	0.14%
Man Group plc	33,567	$238.7K	0.00%
Boothbay Fund Management, LLC	30,710	$218.3K	0.01%
Woodline Partners LP	22,192	$157.8K	0.00%
Bank of New York Mellon Corp	18,845	$134.0K	0.00%
Charles Schwab Investment Management Inc	17,128	$121.8K	0.00%
New York State Common Retirement Fund	13,300	$94.6K	0.00%
Dimensional Fund Advisors LP	12,560	$89.3K	0.00%
Polar Asset Management Partners Inc.	10,781	$76.7K	0.00%
Two Sigma Securities, LLC	10,619	$75.5K	0.00%
Bank of America Corp	9,247	$65.7K	0.00%
Rhumbline Advisers	8,233	$58.5K	0.00%
STRS Ohio	5,300	$37.7K	0.00%
Corebridge Financial, Inc.	3,918	$27.9K	0.00%
JPMorgan Chase & Co	3,104	$22.1K	0.00%
Barclays PLC	2,543	$18.1K	0.00%
Citigroup Inc	1,632	$11.6K	0.00%
Ameritas Investment Partners, Inc.	714	$5.08K	0.00%
Legal & General Group Plc	631	$4.52K	0.00%
California State Teachers Retirement System	528	$3.75K	0.00%
Amalgamated Bank	252	$2.00K	0.00%

Sold out (5)

Institutions that held Climb Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CLYM in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
BML Capital Management, LLC	2,193,742	$6.01M
Atom Investors LP	78,276	$214.5K
Tudor Investment Corp Et Al	29,466	$80.7K
Chicago Partners Investment Group LLC	12,104	$45.4K
Qube Research & Technologies Ltd	981	$2.69K